Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Infliximab ameliorates TNF-α-induced insulin resistance in 3T3L1 adipocytes in vitro by restoring the insulin signalling pathway via PTP1B inhibition
a potent ROCK inhibitor
Smiles: CN1CCN(CC1)C1C=CC(=CC=1)NC1=NC(=CC=N1)N(C1=CC=C(C=C1OC)OC)C(=O)OC1=CC(=CC=C1C)C(=O)NC1=CC(=CC=C1)C(F)(F)F
InChiKey: IPESYYFOXATSFJ-UHFFFAOYSA-N
1253952-02-1 (HCl)
(R)-Pirtobrutinib Size:Contact [email protected] for quotation Infliximab ameliorates TNF-α-induced insulin resistance(R) Pirtobrutinib ((R) LOXO 305) is a less active enantiomer of Pirtobrutinib. Pirtobrutinib (LOXO 305), a highly selective and non covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations. Product information CAS Number: 2101700 14 3 Molecular Weight: 479. 43 Formula: C22H21F4N5O3 Chemical Name: (R) 5 amino 3 (4 ((5 fluoro 2 methoxybenzamido)methyl)phenyl) 1 (1, 1, 1 trifluoropropan 2 yl) 1H pyrazole 4 carboxamide
US$ 19.95
US$ 49.95
US$ 1957.97
US$ 11.99